Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab
Neurology Today in 518 Heinä 2024

Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab

In this week's podcast, Neurology Today's editor-in-chief discusses data on an angiotensin receptor for blocker for hypertension associated with reduced risk for epilepsy, a study finding first responders to 9-11 clean-up sites had an increased risk for early dementia, and dementia experts comment on approval of donanemab.

Jaksot(100)

November 18 - Issue Introduction

November 18 - Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 18, 2021 issue.

19 Marras 20215min

November 4- Issue Introduction

November 4- Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 4, 2021 issue.

8 Marras 20215min

October 21- Issue Introduction

October 21- Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 21, 2021 issue.

21 Loka 20215min

October 7- Issue Introduction

October 7- Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 7, 2021 issue.

7 Loka 20215min

Suosittua kategoriassa Premium

nikotellen
tuplakaak
antin-matka
jaljilla
anni-jaajo
ihan-oikeesti
hei-baby-3
dear-shirly
olipa-kerran-otsikko
maanantaimysteeri
kolme-kaannekohtaa
palmujen-varjoissa
siita-on-vaikea-puhua
piinan-kirous-2
the-harlin-show
sita
terveisia-perheesta
aikalisa
i-dont-like-mondays
tahtitehdas